Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Oral bioavailability of palinavir studied in various animal models

Aug. 11, 1997

Open-label trial of Glaxo Wellcome anti-HIV drug begins

Aug. 11, 1997

DaunoXome approved in Russia

Aug. 7, 1997

FDA advisory panel to review Paxene for KS

Aug. 6, 1997

Paclitaxel approved by FDA for AIDS-related KS

Aug. 6, 1997

NIH study shows TB prophylaxis unnecessary in HIV-infected patients

Aug. 1, 1997

Caelyx approved in Australia and New Zealand

July 31, 1997

New protease inhibitor from HMR characterized

July 30, 1997

Advantage-24 safe for evaluation in HIV prevention

July 29, 1997

Hybridon suspends development of GEM-91 for AIDS

July 28, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...